KEI Briefing Note 2022:2. Federal government FAR 52.227-1 authorizations (for non voluntary use of patents) disclosed in 166 SEC exhibits
Government Funded research
WIPO SCP 34: KEI statement on patents and health
On Tuesday, 27 September 2022, Knowledge Ecology International (KEI) delivered the following oral statement during discussions on patents and health at the 34th session of the WIPO Standing Committee on the Law of Patents (SCP). In July 2022, KEI published… Continue Reading
KEI review of 62 COVID 19 contracts reveals 59 authorizations for non-voluntary use of third party patents under 28 USC 1498
Since the COVID 19 Pandemic began, there has been a spirited debate over patent rights, including a highly publicized 20 month debate over a proposed WTO waiver on intellectual property rights. During that time a handful of countries have taken… Continue Reading
KEI Briefing Note 2022:1, Selected U.S. Government COVID Contracts with Authorization and Consent to Non-Voluntary Use Of Third Party Patents
Human Rights Council heats up during informal talks on inequality, international solidarity, and intellectual property
UPDATE: On Monday, 4 July 2022, a revised version of the Core Group’s access to medicines, vaccines, and other health products resolution (A/HRC/50/L.13) was circulated. The current co-sponsors include: Argentina, Brazil, China, Ecuador,* Egypt,* India, Indonesia, Malaysia, Namibia, Nepal, Paraguay,… Continue Reading
Constituency statement for Knowledge Ecology International, Health Action International, Oxfam, and Public Services International: Strengthening WHO preparedness for and response to health emergencies
On 24 May 2022, I delivered the following constituency statement on behalf of Knowledge Ecology International, Health Action International, Oxfam, and Public Services International on the following topic: “16.2 – Strengthening WHO preparedness for and response to health emergencies” at… Continue Reading
NIH Questioned about Xtandi and March-in Rights during Congressional Hearing
On Wednesday May 11, 2022, the National Institutes of Health (NIH) was asked about Xtandi and march-in rights during a Congressional hearing. The House Appropriations Committee held a hearing on the FY2023 Budget Request for the NIH, and Representative Mark… Continue Reading
KEI Comments Regarding NIH Prospective Exclusive License to Georgetown University for Pancreatic Cancer Diagnostic
On April 28, 2022, Knowledge Ecology International (KEI) provided comments on the latest National Institutes of Health (NIH) Federal Register notice concerning licensing, the “Prospective Grant of an Exclusive Patent License: Development of Diagnostic for Imaging and Early Detection of… Continue Reading
Documents from NIH Freedom of Information requests
ACTIV The National Institutes of Health (NIH) Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership, to develop treatments and vaccines. Coordinated by the Foundation for the National Institutes of Health (FNIH), with the NIH and sibling agencies in the… Continue Reading
Additional Comments for the Public Hearing on the Proposed WHO Treaty on Pandemic Preparedness and Response
These are the additional comments to the WHO Public Hearing on a possible WHO treaty or other instrument on pandemic preparedness and response (KEI also provided oral testimony at the hearing, and filed earlier comments here). Luis Gil Abinader –… Continue Reading